Gene Cluster Produces Multiple Antibiotics to Combat Drug Resistance
A study of Streptomyces bacteria reveals a coordinated attack on bacterial biotin production, offering a new strategy against multidrug-resistant infections.
Category: Other Infections
Other Infections
Latest
Gene Cluster Produces Multiple Antibiotics to Combat Drug Resistance
A study of Streptomyces bacteria reveals a coordinated attack on bacterial biotin production, offering a new strategy against multidrug-resistant infections.
Read More
PCR Testing Improved Detection of Life-Threatening Fungal Infections
Molecular diagnostics provide faster, more accurate identification of mucormycosis and co-infections compared to traditional culture methods.
Read More
Positive Ph3 Data for Aspergillosis Antifungal Treatment
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Read More
FDA Approves Capvaxive Pneumococcal Vaccine for Children 2-17
The USFDA approved an expanded indication for Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) to include children and adolescents aged 2 through 17 years, according to Merck.
Read More
US Measles Total Breaks 2,000 Cases for the Year
A total of 2,073 measles cases have been reported in the United States in 2026 — nearly as many as 2025, which was the worst year for measles infections since 1991.
Read More
Pediatric Risk Factors for Severe Respiratory Infections
Underlying chronic conditions and hospital transfers are major indicators of severe disease in pediatric patients with respiratory tract infections.
Read More
Unique Attack Method for New Antibiotic
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Read More
T Cells May Offer Defense Against Measles, Nipah Virus
New research suggests that activating cross-reactive immune cells could provide a defense against the entire paramyxovirus family, including measles and the deadly Nipah virus.
Read More
COVID-19 Travel Lessons for Hantavirus, Ebola
Recent outbreaks of Hantavirus and Ebolavirus raise concerns about risks linked to travel, with responses varying between countries.
Read More
First Lung Transplant for HIV Patient in San Diego County
UC San Diego Health successfully completed the first lung transplant for a patient with HIV in San Diego County.
Read More
Wastewater Testing Detects C. auris Months Before Outbreaks
Sampling sewage lines directly serving healthcare facilities allows scientists to identify...
Read More
NASCAR Champion Dies of Pneumonia-related Sepsis
A two-time NASCAR champion driver died Thursday from severe pneumonia that progressed into sepsis, according to multiple media outlets.
Read More
Worse COPD, Pneumonia Outcomes at Private Equity Hospitals
Patients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read More
Tuberculosis Costs the World $1.35 Trillion Annually
New research indicates tuberculosis drains 0.8% of the world’s economic potential annually, disproportionately affecting low- and middle-income countries.
Read More
Human Antibodies Could Lead to First Measles Treatment
Specific antibodies can neutralize the measles virus and reduce viral loads in preclinical models.
Read More
Delirium Screening, Fall Prevention, Pneumonia Prevention Improve Post-Surgical Outcomes
Implementing specific protocols for older surgical patients can reduce complications such as delirium, falls, and pneumonia.
Read More
Bronchiectasis + Chronic Rhinosinusitis Patients More Likely to Have P. aeruginosa in Mucus
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
Hantavirus Outbreak Highlights Person-to-Person Transmission Risks
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
Read More
New CRISPR Can Shred Infected Cells’ DNA
Researchers have developed a new form of CRISPR technology that destroys harmful cells instead of editing their genes, while leaving healthy tissue untouched.
Read More
Hantavirus Outbreak on Cruise Ship Leads to Three Deaths
The World Health Organization is tracking a cluster of hantavirus and three fatalities linked to a South Atlantic voyage.
Read More
Valley Fever Linked to Fungal Spores Spread by Extreme Weather, Dust
A decade-long study shows a significant rise in respiratory infections caused by fungal spores released during intense wind and heat events in El Paso Texas.
Read More
Similar CAP Outcomes for Short vs Long Antibiotic Courses
A short course of antibiotics was similarly effective to a longer course for patients hospitalized with community-acquired pneumonia (CAP).
Read More
Inhaled Nanomedicine Targets Tuberculosis in the Lungs
A new delivery system allows four standard tuberculosis medications to be inhaled directly into the respiratory tract, potentially reducing side effects and improving treatment adherence.
Read More
Tuberculosis Survivors Face Elevated Mortality Risk for 14 Years After Treatment
Even after successful treatment completion, tuberculosis patients experience higher rates of death from respiratory and cardiovascular causes.
Read More